whether abruptly stopping clopidogrel (Plavix) can worsen cardiovascular outcomes

March 2008

A recent JAMA study has people asking whether abruptly stopping clopidogrel (Plavix) can worsen cardiovascular outcomes.

Acute coronary syndrome patients seem to have about twice the risk of death or heart attack within 90 days of stopping clopidogrel.

Researchers speculate it's a possible "rebound effect."

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote